According to a study released by Centers for Disease Control (CDC), consumer out-of-pocket spending on opioids has declined, with insurers picking up more of the tab.
The study found that consumer out-of-pocket spending on opioids per 100 morphine milligram equivalents declined from $4.40 in 2001 to 90 cents 2012, with insurers paying an increasingly larger share of the cost.
Deaths from drug overdose have dramatically increased in recent years and are now the leading cause of injury death in the United States, according to the CDC. Deaths from prescription opioid overdose quadrupled between 1999 and 2013.
According to the study, changes in financing and cost of opioid pain relievers coincide with the large increase in overdose deaths associated with these drugs.
Prescription opioid drug spending grew dramatically from 1999 to 2012. Americans spent $2.3 billion on prescription opioids in 1999. By 2006, spending had almost tripled to over $7.0 billion.
In 1999, 53 percent of spending on opioid pain relievers was out-of- pocket, but by 2012, out-of-pocket spending had declined to 18 percent of all expenditures.
The most dramatic change in the financing of opioid pain relievers occurred in the public insurance sector. In 1999, Medicare and Medicaid paid for 9 percent of opioid drug spending (1 percent and 8 percent, respectively). In 2006, the Medicare prescription drug benefit (Medicare Part D) was implemented. Since this time, Medicare has been the largest payer (about 30 percent) for opioid pain relievers.
The new study “Payments for Opioids Shifted Substantially to Public and Private Insurers While Consumer Spending Declined, 1999-2012,” released in Health Affairs, documents a decline in opioid drug unit costs after 2006 as well. Medicare spent considerably more for prescription opioids for enrollees younger than age 65 than any other payer spent for prescription opioids for patients of all ages.
CDC is developing opioid prescribing guidelines to help primary care doctors provide safer, more effective care for patients with chronic pain, and working to equip health care providers with data and guidance so they can make informed treatment decisions.
Was this article valuable?
Here are more articles you may enjoy.